First, we analyzed the CPTAC database and found that NSUN5 expression was significantly increased in colorectal cancer, clear cell renal carcinoma, lung cancer, pancreatic cancer, head and neck cancer, gliomas, and liver cancer (Figure 2A). Here, NSUN5 is linked to liver cancer.